 |
Director's Notes Archive
2009
- 04/03/2009 - The Most Promising Opportunity
Last week I had the pleasure of addressing the NCI Director's Consumer Liaison Group, informally known as the DCLG. The DCLG held its spring meeting in Austin, Texas, where they hosted a forum to explore community priorities. The members also discussed the American Recovery and Reinvestment Act of 2009 (Recovery Act) and the opportunities for progress it presents.
- 03/19/2009 - NCI Funding For Individual Scientists
In the cancer research community, one of the most tangible signs of NCI's commitment to outstanding science is our vigorous support of individual scientists. While NCI uses many different mechanisms to fund laboratory and translational science, the Research Project Grant, better known as the R01, makes up the largest single segment of NCI's budget.
- 03/13/2009 - Managing the National Cancer Institute
In any fiscal climate, managing NCI's portfolio is a complex proposition. Consider, if you will, that in a typical year, NCI's Office of Grants Administration will handle almost 12,000 transactions from more than 740 organizations - grants that range from $1,000 to $30 million per year, across 57 funding mechanisms, totaling $3.2 billion.
|
|
|
|
